Early Development Asset Lead - Shape Translational Strategy
Listed on 2026-10-16
-
Management
Corporate Strategy, Project & Program Management
Ipsen seeks an experienced Early Development Asset Lead to manage integrated strategies for one or more early-stage assets from nomination through first-in-human trials. You will lead the EDT, coordinating clinical, regulatory, translational, and nonclinical teams to advance programs with scientific rigor and portfolio alignment.
The role requires a PhD/MD/PharmD or equivalent with 10–15 years in multidisciplinary drug development, and strong leadership in a global, matrix organization.
This role, Early Development Asset Lead
- Shape Translational Strategy at Ipsen, could be your next move.
Are you ready to take on the Early Development Asset Lead
- Shape Translational Strategy role at Ipsen?
We would love to welcome a new Early Development Asset Lead
- Shape Translational Strategy to our organisation in England, United Kingdom.
For the Early Development Asset Lead
- Shape Translational Strategy position at Ipsen, we are reviewing applications now.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).